Cargando…

Vancomycin is commonly under‐dosed in critically ill children and neonates

AIMS: Vancomycin is frequently used in critically ill children in whom the drug pharmacokinetics are significantly altered as a result of changes in renal clearance and volume of distribution. Therapeutic drug monitoring (TDM) is recommended to achieve vancomycin trough concentrations between 10 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sosnin, Natasha, Curtis, Nigel, Cranswick, Noel, Chiletti, Roberto, Gwee, Amanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848905/ https://www.ncbi.nlm.nih.gov/pubmed/31378957 http://dx.doi.org/10.1111/bcp.14084

Ejemplares similares

Protocol for a randomised controlled trial of continuous infusions of vancomycin to improve the attainment of target vancomycin levels in young infants: The VANC trial
por: Gwee, Amanda, et al.
Publicado: (2018)

ECMO for Neonatal Sepsis in 2019
por: Butt, Warwick Wolf, et al.
Publicado: (2020)

External Validation of Model-Based Dosing Guidelines for Vancomycin, Gentamicin, and Tobramycin in Critically Ill Neonates and Children: A Pragmatic Two-Center Study
por: Hartman, Stan J. F., et al.
Publicado: (2020)

Stabilization of the critically ill neonate awaiting transport
por: Gente, Maurizio, et al.
Publicado: (2015)

Using Electronic Health Records for Personalized Dosing of Intravenous Vancomycin in Critically Ill Neonates: Model and Web-Based Interface Development Study
por: Hui, Ka Ho Matthew, et al.
Publicado: (2022)

Vancomycin as a single daily dose in critically ill patients on an intensive care unit
por: Grundler, S, et al.
Publicado: (2000)

A higher dose of vancomycin is needed in critically ill patients with augmented renal clearance
por: He, Juan, et al.
Publicado: (2020)

Population Pharmacokinetics and Dosing Simulation of Vancomycin Administered by Continuous Injection in Critically Ill Patient
por: Garreau, Romain, et al.
Publicado: (2021)

Population pharmacokinetics and dose optimization of vancomycin in neonates
por: Lee, Soon Min, et al.
Publicado: (2021)

Pharmacokinetics of Vancomycin in Critically Ill Children: A Systematic Review
por: Akunne, Onyinye Onyeka, et al.
Publicado: (2021)

1110. In Vivo Pharmacodynamics of Vancomycin Against Staphylococci in Young Infants
por: Gwee, Amanda, et al.
Publicado: (2021)

Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance Measurement
por: Shahrami, Bita, et al.
Publicado: (2020)

A Systematic Review on Clinical Safety and Efficacy of Vancomycin Loading Dose in Critically Ill Patients
por: Haseeb, Abdul, et al.
Publicado: (2022)

Optimizing Vancomycin Therapy in Critically Ill Children: A Population Pharmacokinetics Study to Inform Vancomycin Area under the Curve Estimation Using Novel Biomarkers
por: Downes, Kevin J., et al.
Publicado: (2023)

Index for the appropriate vancomycin dosing in premature neonates and infants
por: Endo, Aiju, et al.
Publicado: (2021)

Impact of a vancomycin loading dose on the achievement of target vancomycin exposure in the first 24 h and on the accompanying risk of nephrotoxicity in critically ill patients
por: Hodiamont, C J, et al.
Publicado: (2021)

Predictors of acute kidney injury under continuous infusion of vancomycin in critically ill surgical patients
por: Chackupurakal, R, et al.
Publicado: (2015)

Population pharmacokinetics of ivermectin for the treatment of scabies in Indigenous Australian children
por: Gwee, Amanda, et al.
Publicado: (2020)

Efficacy and safety of vancomycin loading doses in critically ill patients with methicillin-resistant Staphylococcus aureus infection
por: Flannery, Alexander H., et al.
Publicado: (2021)

The Significance of Bayesian Pharmacokinetics in Dosing for Critically Ill Patients: A Primer for Clinicians Using Vancomycin as an Example
por: Alnezary, Faris S., et al.
Publicado: (2023)

Effects of continuous venovenous hemofiltration on vancomycin trough concentrations in critically ill children
por: Peng, Lengyue, et al.
Publicado: (2021)

64. Novel Biomarkers Improve Estimation of Vancomycin Clearance in Critically Ill Children
por: Downes, Kevin J, et al.
Publicado: (2021)

Prospective validation of neonatal vancomycin dosing regimens is urgently needed
por: Vandendriessche, Anaïs, et al.
Publicado: (2014)

Usefulness of serum cystatin C to determine the dose of vancomycin in neonate
por: Shin, Jeong Eun, et al.
Publicado: (2015)

Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates
por: Mulubwa, Mwila, et al.
Publicado: (2020)

Usefulness of vancomycin serum concentration monitoring in the critically ill patient
por: Bertolissi, M, et al.
Publicado: (2000)

Serum Creatinine and Serum Cystatin C are Both Relevant Renal Markers to Estimate Vancomycin Clearance in Critically Ill Neonates
por: Leroux, Stéphanie, et al.
Publicado: (2021)

Decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogram
por: Baptista, João Pedro, et al.
Publicado: (2014)

Effect of vancomycin loading dose on clinical outcome in critically ill patients with methicillin-resistant Staphylococcus aureus pneumonia
por: Yoon, Jin Gu, et al.
Publicado: (2021)

Dose Optimization of Vancomycin for Critically Ill Patients Undergoing CVVH: A Prospective Population PK/PD Analysis
por: Wang, Chuhui, et al.
Publicado: (2021)

Continuous Vancomycin Infusion versus Intermittent Infusion in Critically Ill Patients
por: Maluangnon, Chailat, et al.
Publicado: (2022)

Development of a vancomycin dosing approach for critically ill patients receiving hybrid hemodialysis using Monte Carlo simulation
por: Lewis, Susan J, et al.
Publicado: (2018)

Single-dose and Steady-state Pharmacokinetics of Vancomycin in Critically Ill Patients Admitted to Medical Intensive Care Unit of India
por: Mali, Nitin B, et al.
Publicado: (2019)

Vancomycin Prescribing Practices and Therapeutic Drug Monitoring for Critically Ill Neonatal and Pediatric Patients: A Survey of Physicians and Pharmacists in Hong Kong
por: Chow, Twinny Cheuk Hin, et al.
Publicado: (2020)

The relationship between vancomycin AUC/MIC and trough concentration, age, dose, renal function in Chinese critically ill pediatric patients
por: Chen, Jihui, et al.
Publicado: (2021)

Comparison of Race‐Based and Non–Race‐Based Equations for Kidney Function Estimation in Critically Ill Thai Patients for Vancomycin Dosing
por: Sitaruno, Sirima, et al.
Publicado: (2022)

Continuous-Infusion Vancomycin in Neonates: Assessment of a Dosing Regimen and Therapeutic Proposal
por: Tauzin, Manon, et al.
Publicado: (2019)

1772. Vancomycin-Resistant Enterococcus Alters the Gastrointestinal Microbiome in Critically Ill Patients
por: Cuaresma, Edward, et al.
Publicado: (2018)

Enteral Vancomycin to Eliminate MRSA Carriership of the Digestive Tract in Critically Ill Patients
por: Buitinck, Sophie H., et al.
Publicado: (2022)

Volume of distribution as an early predictor of vancomycin-induced AKI in critically ill patients
por: Ghasemiyeh, Parisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7unj23vjbkb0s9l9o2g9htqud9